tiprankstipranks
Madrigal Pharmaceuticals upgraded to Buy from Neutral at B. Riley
PremiumThe FlyMadrigal Pharmaceuticals upgraded to Buy from Neutral at B. Riley
4d ago
Madrigal Pharmaceuticals price target raised to $443 from $427 at Citizens JMP
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $443 from $427 at Citizens JMP
4d ago
Madrigal Pharmaceuticals price target raised to $475 from $400 at Oppenheimer
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $475 from $400 at Oppenheimer
4d ago
Madrigal Pharmaceuticals Reports Strong Rezdiffra Sales
PremiumCompany AnnouncementsMadrigal Pharmaceuticals Reports Strong Rezdiffra Sales
5d ago
Buy Rating for Madrigal Pharmaceuticals Driven by Strong Financials and Promising Clinical Trial Results
Premium
Ratings
Buy Rating for Madrigal Pharmaceuticals Driven by Strong Financials and Promising Clinical Trial Results
5d ago
Madrigal Pharmaceuticals Phase 3 data ‘encouraging,’ says UBS
Premium
The Fly
Madrigal Pharmaceuticals Phase 3 data ‘encouraging,’ says UBS
5d ago
Madrigal Pharmaceuticals price target raised to $400 from $336 at Piper Sandler
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $400 from $336 at Piper Sandler
17d ago
Akero cirrhosis data positive for Madrigal, says Piper Sandler
Premium
The Fly
Akero cirrhosis data positive for Madrigal, says Piper Sandler
1M ago
Madrigal dip on Akero data a buying opportunity, says Evercore ISI
Premium
The Fly
Madrigal dip on Akero data a buying opportunity, says Evercore ISI
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100